---
title: "Autolus raises FY 2026 sales forecast to $140 million-$150 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294684108.md"
description: "Autolus Therapeutics raised its FY 2026 sales forecast to $140 million-$150 million, up from the previous guidance of $120 million-$135 million. Preliminary Q2 2026 net product revenue for AUCATZYL is estimated at approximately $45 million, representing a 70% increase from Q1 2026. Additionally, year-to-date gross margin is estimated at about 35%, showing significant improvement from -20% in the second half of 2025."
datetime: "2026-08-03T11:13:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294684108.md)
  - [en](https://longbridge.com/en/news/294684108.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294684108.md)
generator: "portal-rs"
---

# Autolus raises FY 2026 sales forecast to $140 million-$150 million

-   Autolus raised FY 2026 sales guidance to $140 million-$150 million from $120 million-$135 million. \* Preliminary Q2 2026 AUCATZYL net product revenue seen at about $45 million; up about 70% vs Q1 2026. \* Year-to-date gross margin estimated at about 35%, improving from about -20% in 2H 2025. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autolus Therapeutics plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030713PRIMZONEFULLFEED9802401) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)

## Related News & Research

- [Autolus says FDA grants RMAT designation for obe-cel in lupus, lupus nephritis](https://longbridge.com/en/news/298445726.md)
- [Chime raises 2026 revenue outlook to $2.76-$2.77 billion](https://longbridge.com/en/news/298359842.md)
- [Essex Property Trust declares Q3 2026 dividend of R$ 0.89 per unit](https://longbridge.com/en/news/298322539.md)
- [Annaly Capital declares Q3 2026 dividend of $0.75 per share](https://longbridge.com/en/news/298499808.md)
- [Acteos delays H1 2026 results release to Oct. 28](https://longbridge.com/en/news/298618428.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**